<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202601</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[Association between gestational diabetes mellitus and brain development in very preterm infants: A quantitative 3D-ASL study]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.001</link>
<description><![CDATA[<b>Objective</b>To use three-dimensional arterial spin labeling (3D-ASL) imaging technology to measure cerebral blood flow (CBF) in very premature infants born to mothers with gestational diabetes mellitus (GDM) and to analyze its correlation with metabolic and inflammatory markers in these infants. <b>Materials and Methods</b>One hundred very premature infants were recruited from the Third Affiliated Hospital of Zhengzhou University between April 2024 and March 2025. The infants were divided into a GDM group consisting of 50 cases and a control group including 50 cases. Both groups performed 3D T1 BRAVO, 3D-ASL, and normal MRI sequence scans. General clinical data and CBF values across several brain regions were gathered and analyzed across the two groups. The correlation between CBF values in markedly distinct brain areas and the initial blood glucose levels and inflammatory markers was examined. <b>Results</b>In comparison to the control group, the very premature infants in the GDM group had significantly higher birth weight, CBF values in multiple brain regions (left frontal lobe, right temporal lobe, bilateral occipital lobes, and bilateral basal ganglia), along with increased inflammatory markers (<i>P </i>&lt; 0.05). The initial blood glucose levels in the GDM group were markedly lower than those in the control group (<i>P </i>&lt; 0.05). The CBF values in the brain regions exhibiting differences between the two groups were positively correlated with procalcitonin levels (<i>r</i> = 0.665, 0.518, 0.627, 0.582, 0.495, 0.465, <i>P</i> &lt; 0.05) and negatively correlated with initial blood glucose levels (<i>r</i> = -0.409, -0.448, -0.450, -0.447, -0.487, -0.501, <i>P </i>&lt; 0.05). <b>Conclusions</b>3D-ASL technology offers a noninvasive and dependable imaging modality for assessing brain development in very premature infants born to mothers with GDM. Alterations in blood flow parameters connect with clinical signs, providing significant references for the early detection and personalized management in these newborns, perhaps enhancing their prognosis. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Alterations of spontaneous brain activity and functional connectivity in chronic smokers: A resting state magnetic resonance imaging study]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.002</link>
<description><![CDATA[<b>Objective</b>To detect the alterations of spontaneous brain activity and functional connectivity (FC) in chronic smokers employed the method of amplitude of low-frequency fluctuation (ALFF) combined with FC. <b>Materials and Methods</b>A total of 27 chronic smokers and 30 healthy controls were enrolled in this current study, which was matched with age and gender. All participants underwent neuropsychological assessments and resting-state functional magnetic resonance imaging (rs-fMRI) scans. The DPABI 6.0 and SPM 12.0 software were used to analyze the brain regions with abnormal ALFF values. The brain region with abnormal ALFF values was selected as the see region of interest (ROI) for the whole brain functional connectivity analysis. <b>Results</b>Compared with the health controls, the chronic smokers exhibited increased ALFF value in the left superior frontal gyrus (SFG) and a decreased ALFF value in the right cerebellar hemispheres. Additionally, the current study found increased FC between the left SFG and the left parietal gyrus, and we also found increased FC between the left SFG and the right parietal gyrus (GRF correction, voxel-level <i>P</i> &lt; 0.001 cluster-level <i>P</i> &lt; 0.05). <b>Conclusions</b>Abnormal brain activity and functional connectivity of the frontal gurus, parietal gyrus and cerebellum may be the reason of addiction in chronic smokers, which may provide imaging evidence to reveal the neurobiological mechanisms in chronic smokers. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Alterations in the structures of subcortical nuclei and structural covariance network properties in classic trigeminal neuralgia]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.003</link>
<description><![CDATA[<b>Objective</b>To explore the variation characteristics of gray matter volume (GMV) and GMV-based structural covariance network (SCN) of subcortical nuclear structures in patients with classic trigeminal neuralgia (CTN). <b>Materials and Methods</b>The 3D-T1WI structural image data of 55 patients with classic CTN and 59 healthy controls were prospectively collected, and the GMV of bilateral thalamus, hippocampus and amygdala subregions was extracted, and calculate the SCN at the group level based on the GMV of each subject. Compare the differences in GMV and SCN parameters between the two groups respectively. <b>Results</b>CTN patients showed volume reduction in the left anteriorventral, paracentral, parafascicular, right laterodorsal, central medial, reuniens medial ventral and bilateral ventromedial in the subregions of the thalamus (<i>P </i>&lt; 0.001). In the amygdala subregion, the volumes of the right accessory basal nucleus, the anterior amygdaloid area, the cortico-amygdaloid transition area, and the bilateral cortical nucleus (<i>P </i>&lt; 0.001) decreased; in the hippocampal subregion, the volume of the left cornu ammonis 4-body and the granule cell layer of the dentate gyrus-body (<i>P </i>≤ 0.001) decreased. Partial correlation analysis indicated that the duration of pain in the CTN patient group was negatively correlated with the volumes of the left ventromedial, the left parafascicular, the right ventromedial and the right central medial (<i>r</i><sub>s </sub>= -0.397, <i>P </i>= 0.003; <i>r</i><sub>s </sub>= -0.435, <i>P</i> &lt; 0.001; <i>r</i><sub>s </sub>= -0.306, <i>P</i> = 0.023 and <i>r</i><sub>s </sub>= -0.323, <i>P</i> = 0.016, respectively), the score of the self-rating anxiety scale was positively correlated with the volume of the right cortico-amygdaloid transition area and the right accessory basal nucleus (<i>r</i><sub>s </sub>= 0.257, <i>P</i> = 0.059 and <i>r</i><sub>s </sub>= 0.349, <i>P </i>= 0.009, respectively). The small-world index of SCN in the CTN group was significantly lower than that in the control group (<i>P </i>&lt; 0.05). <b>Conclusions</b>The important subregions of subcortical nuclear structure in CTN patients show volume reduction and changes in network properties. These findings suggest that the alterations in subcortical nuclear structure and structural covariance network characteristics, as potential structural feature markers of CTN, are expected to provide new targets for pain treatment. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A study on the brain network connectivity of adolescent depression patients with childhood trauma treated with eye movement desensitization and reprocessing combined with sertraline based on rs-fMRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.004</link>
<description><![CDATA[<b>Objective</b>To investigate brain functional network changes in adolescents with depression and childhood trauma after eye movement desensitization and reprocessing (EMDR) combined with sertraline versus sertraline monotherapy, and evaluate the advantages of combined therapy. <b>Materials and Methods</b>A total of 67 adolescent patients with depression and childhood trauma were enrolled. General demographic data and Hamilton Depression Rating Scale (HAMD) scores were collected. Participants were divided into two groups: 33 receiving EMDR combined with sertraline and 34 receiving sertraline monotherapy. All underwent 8-week treatment. Clinical evaluations included the Hamilton Depression Rating Scale (HAMD). Pre- and post-treatment resting-state and structural imaging data were acquired. Functional connectivity matrices were constructed using average blood oxygen level-dependent (BOLD) signals from 142 regions of interest (ROI) defined by the cerebellum-removed Dosenbach atlas. Paired-sample <i>t</i>-tests compared intergroup differences in functional connectivity matrices. Differential edges were categorized into large-scale brain networks using the Yeo7 model, and the number of differential edges within/between seven networks was calculated. <b>Results</b>Both groups showed significant HAMD score reductions (combined therapy: <i>t </i>= 16.11, <i>P</i> &lt; 0.001; monotherapy: <i>t </i>= 13.20, <i>P</i> &lt; 0.001) and widespread brain functional connectivity changes. The combined therapy group had 49 differential ROIs and 39 differential edges (all <i>P</i> &lt; 0.05), with reduced connectivity primarily within the default mode network (DMN) and ventral attention network (VAN), and increased connectivity between DMN-frontoparietal network (FPN) and DMN-dorsal attention network (DAN). The sertraline group had 32 differential ROIs and 19 differential edges (all <i>P</i> &lt; 0.05), with reduced connectivity mainly within DMN and increased connectivity involving DAN. <b>Conclusions</b>Both treatments demonstrated effective antidepressant outcomes. Combined therapy induced enhanced DMN-FPN connectivity, suggesting improved coordination between cognitive flexibility and emotion regulation, with broader therapeutic effects compared to monotherapy. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Value of interpretable machine learning models based on sMRI in predicting aggressive and violent behaviors in schizophrenia patients]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.005</link>
<description><![CDATA[<b>Objective</b>Through voxel-based morphometry (VBM), the structural magnetic resonance imaging (sMRI) features of schizophrenia (SCZ) patients with and without aggressive violence were compared, and a machine learning model was constructed to realize the early identification and prediction of SCZ patients with aggressive violence. <b>Materials and Methods</b>A retrospective analysis of 146 patients diagnosed with SCZ in Shandong Daizhuang Hospital from March 2023 to June 2025, including 77 SCZ patients with aggressive violence and 69 SCZ patients without aggressive violence. The differences of clinical indicators and sMRI features between the aggressive violence group and the non-aggressive violence group were compared, and the prediction model of aggressive violence in SCZ patients was constructed. Among the four machine learning prediction models, the area under the curve (AUC) of logistic regression (LR), decision tree (DT), random forest (RF) and support vector machine (SVM) were 0.824, 0.821, 0.917 and 0.940, respectively. The results of DeLong test showed that the AUC of LR, DT, RF and SVM were 0.824, 0.821, 0.917 and 0.940, respectively. The predictive performance of the SVM model was the highest (<i>P </i>&lt; 0.05). The SHAP (SHapley Additive exPlanations) summary map results showed that the thickness of the left insular cortex was the most important feature for predicting aggressive violence in schizophrenia. Decision curve analysis (DCA) showed that the four models had high guiding significance for clinical practice. <b>Results</b>There was no significant difference in clinical indicators between the aggressive violence group and the non-aggressive violence group (<i>P </i>&gt; 0.05). The thickness of the left insular cortex, the thickness of the left fusiform cortex, the Gaussian curvature of the left operculum, the thickness of the right insular cortex, the mean curvature of the left operculum, and the thickness of the right middle and posterior prefrontal cortex in the aggressive violence group were lower than those in the non-aggressive violence group (<i>P </i>&lt; 0.05). <b>Conclusions</b>Machine learning models based on sMRI can predict aggressive and violent behaviors in SCZ patients, with the SVM model exhibiting the highest predictive performance. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Correlation between arterial recanalization and the susceptibility vessel sign following endovascular therapy in patients with acute ischemic stroke]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.006</link>
<description><![CDATA[<b>Objective</b>To investigate the relationship between arterial recanalization after endovascular treatment and the length and width of the susceptibility vessel sign (SVS), and to evaluate the relationship between successful arterial recanalization after endovascular treatment and various risk factors. <b>Materials and Methods</b>We retrospectively analyzed the patients with anterior circulation ischemic stroke who underwent magnetic resonance imaging (MRI) of the head and susceptibility-weighted imaging (SWI) before endovascular treatment, and measured the SVS length and width. To reduce the variation of SVS width caused by different parts and individual differences, divide the width of the SVS on the affected side by the width of the healthy blood vessel to obtain the relative width of the SVS. At the end of endovascular treatment, those who achieved an assessment of 2b50-3 in the expanded thrombolysis in cerebral infarction (eTICI) were classified as the successful recanalization group, while those who did not reach this level were classified as the unsuccessful recanalization group. Stepwise regression was used to screen variables, and the indicators with statistically significant differences were included in the multivariate logistic regression analysis to determine the independent predictors of successful recanalization and first-pass reperfusion (FPR) after endovascular treatment. <b>Results</b>Among 112 patients, 79 cases achieved successful recanalization and 33 cases did not,within the successful recanalization group, there were 39 cases of FPR. The median width of SVS in the successful recanalization group and the unsuccessful recanalization group was 4.3 (4.1, 4.6) mm and 3.2 (3.0, 3.9) mm, respectively, with <i>P</i> &lt; 0.001, indicating a statistically significant difference; the median length of SVS was 10.6 (9.5, 13.1) mm and 10.5 (7.5, 14.5) mm, respectively, with <i>P</i> = 0.871, indicating no statistically significant difference. In the multivariate logistic regression analysis, SVS width was associated with successful recanalization [odds ratio = 3.025; 95% confidence interval (<i>CI</i>): 4.895 to 24.564; <i>P </i>= 0.001] and FPR (odds ratio = 9.243; 95% <i>CI</i>: 3.493 to 14.460; <i>P </i>&lt; 0.001). The optimal cutoff value for the SVS width to predict successful recanalization and FPR were 3.95mm and 3.85 mm, respectively. <b>Conclusions</b>The width of SVS is a potential imaging biomarker for predicting successful reperfusion of arteries and FPR after endovascular treatment. The length of SVS has no significant predictive value. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Value of DCE-MRI-based tumor heterogeneity quantification and deep learning in predicting neoadjuvant chemotherapy response in breast cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.007</link>
<description><![CDATA[<b>Objective</b>To explore the value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)-based tumor heterogeneity quantification integrated with deep learning (DL) in predicting the pathological complete response of neoadjuvant chemotherapy (NAC) for breast cancer. <b>Materials and Methods</b>The clinical and imaging data of 179 patients with pathologically confirmed breast cancer at the First Affiliated Hospital of Wannan Medical College from January 2019 to January 2025 were retrospectively collected. Among them, 58 patients achieved pathological complete response (pCR) after NAC, and 121 patients achieved non-pathological complete response (non-pCR). The patients were randomly divided into a training group (<i>n </i>= 125) and a validation group (<i>n </i>= 54) at a ratio of 7∶3. All patients underwent MRI examination before NAC. The ITK-SNAP software was used to manually delineate the region of interest (ROI) layer by layer and perform three-dimensional fusion. The Gaussian mixture model (GMM) was used for cluster analysis, and the Bayesian information criterion (BIC) was used to determine the sub-regions of the tumor lesions. The intratumoral heterogeneity score (ITH-score) was calculated, and a habitat imaging model was established. The PyRadiomics package in Python software was used to extract the traditional radiomics features of the whole tumor, and the ViT deep learning model was used to extract the deep learning features. The minimum redundancy maximum relevance (mRMR) and least absolute shrinkage and selection operator (LASSO) regression methods were used for feature dimensionality reduction and screening. A traditional radiomics model and a deep learning model were constructed respectively, and the quantitative score of each patient was calculated according to the feature weights in the models. Multivariate logistic regression analysis was used to construct a clinical model and a combined model. Receiver operating characteristic (ROC) curves were drawn to evaluate the predictive efficacy of each model. The DeLong test was used to compare the efficacy of each model, and decision curve analysis (DCA) was used to analyze the clinical benefits of the models. The SHAP method was used to analyze the importance of each feature in the combined model. <b>Results</b>The AUC [95%<i> </i>(confidence interval, <i>CI</i>)] values of the clinical model, traditional radiomics model, deep learning model, habitat imaging model, and combined model in predicting pCR after NAC in the training group were 0.864 (0.832 to 0.895), 0.776 (0.745 to 0.807), 0.728 (0.703 to 0.752), 0.823 (0.785 to 0.881), and 0.943 (0.903 to 0.983) respectively, and in the validation group were 0.732 (0.684 to 0.781), 0.634 (0.589 to 0.679), 0.757 (0.720 to 0.791), 0.750 (0.690 to 0.840), and 0.875 (0.821 to 0.929) respectively. The combined model had the best predictive performance. The DCA results showed that the clinical benefit of the combined model was higher than that of the clinical model and other radiomics models. In the SHAP method, the importance of the ITH-score was higher than that of the molecular subtype. The larger the SHAP value, the more the prediction result tended to pCR. <b>Conclusions</b>The combined model based on DCE-MRI heterogeneity quantitative analysis and deep learning demonstrates superior predictive performance for pCR in breast cancer patients after NAC, which holds clinical application value for early prediction of pCR after NAC and contributes to clinical diagnosis and treatment management of breast cancer. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The advantage of gadoxetate disodium-enhanced MRI in differentiating focal chronic inflammatory lesions of the liver from solitary hepatic metastases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.008</link>
<description><![CDATA[<b>Objective</b>To explore the diagnostic value of gadoxetic acid disodium (Gd-EOB-DTPA) enhanced MRI in differentiating of focal chronic inflammatory hepatic lesions (FCIHL) from solitary hepatic metastasis (SHM). <b>Materials and Methods</b>The imaging and clinical data of 23 patients with FCIHL and 36 patients with SHM pathologically confirmed in the Shunde Hospital of Guangzhou University of Chinese Medicine from June 2019 to February 2024 were retrospectively collected. All patients underwent diffusion-weighted imaging (DWI) and gadoxetic acid disodium (Gd-EOB-DTPA) enhanced MRI examinations. The imaging characteristics and clinical indicators were compared between the two groups. Kappa test or intra-class correlation coefficient (ICC) was used to assess the consistency between two observers in each image interpretation. For clinical and imaging data of the two groups that conformed to normal distribution, independent samples <i>t</i>-test was adopted; for other continuous data, Mann-Whitney <i>U</i> test was applied; and for categorical data, chi-square test was used to analyze inter-group differences. Logistic regression analysis was conducted on variables with significant inter-group differences (<i>P</i> &lt; 0.05) to identify the independent risk factors for FCIHL. A nomogram was constructed, and receiver operating characteristic (ROC) curves were plotted to obtain the area under the curve (AUC) values. <b>Results</b>Interobserver consistency between the two observers was excellent, with all ICC or Kappa values greater than 0.8 (all <i>P</i> &lt; 0.05). The apparent diffusion coefficient (ADC) value and the diameter difference of lesions between T2WI and hepatobiliary phase were independent influencing factors for differentiating FCIHL from SHM, with AUC values of 0.787 (95% <i>CI</i>: 0.671 to 0.904) and 0.836 (95% <i>CI</i>: 0.737 to 0.936), respectively (both <i>P</i> &lt; 0.05). The comprehensive AUC value of the nomogram is higher than that of a single indicator, reaching 0.908 (95% <i>CI</i>: 0.836 to 0.980). <b>Conclusions</b>Gd-EOB-DTPA-enhanced MRI has certain value in differentiating FCIHL from SHM. Among these imaging features, the diameter difference of lesions between T2WI and hepatobiliary phase is the most valuable discriminative indicator. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Prediction of treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer by interpretable model based on multiparametric MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.009</link>
<description><![CDATA[<b>Objective</b>To establish a prediction model based on multiparametric MRI radiomics and clinical-radiology features, and evaluate its efficacy in predicting neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer. The Shapley algorithm was employed to enhance model interpretability. <b>Materials and Methods</b>A retrospective analysis was conducted on 172 patients who received nCRT and surgery from the First Affiliated Hospital of the University of Science and Technology of China (center 1) and the Hefei Cancer Hospital of the Chinese Academy of Sciences (center 2), and Clinical and MRI data were analyzed. According to the 8th edition AJCC tumor regression grading (TRG) criteria for rectal cancer, patients with TRG 0-1 were classified as good responders (GR), while those with TRG 2-3 were classified as poor responders (PR) based on postoperative pathological results. The GR group comprised 77 patients, and the PR group comprised 95 patients. Patients from center 1 were randomly divided into a training set (<i>n </i>= 92) and an internal validation set (<i>n </i>= 40), while the patients from center 2 were utilized as an independent external validation set (<i>n </i>= 40). High-resolution axial T2WI, diffusion-weighted imaging (DWI) and sagittal contrast-enhanced T1WI (CE-T1WI) sequences were selected to delineate the region of interest (ROI) along the tumor margins. PyRadiomics software was used to extract all radiomics features after image preprocessing. Spearman correlation analysis and least absolute shrinkage and selection operator (LASSO) analysis were used to retain the radiomics features strongly associated with the efficacy of nCRT. T2WI, DWI, CE-T1WI and multiparametric radiomics score (Rad-score) were obtained by eXtreme gradient boosting (XGBoost) classifier. The independent clinical-radiology predictors were screened by single-multiple logistic regression to build the clinical-radiology model, and the multiparametric model Rad-score combined with independent clinical-radiology predictors was selected to build the nomogram model. The performance of the model was evaluated using receiver operating characteristic (ROC) curves. The best-performing radiomics model was explained by the Shapley algorithm. <b>Results</b>Univariate and multivariate logistic regression analysis identified age, tumor longest diameter, and neoadjuvant treatment modalities as independent predictors for treatment efficacy. The clinical-radiology model demonstrated the area under the curve (AUC) of 0.80 (95% <i>CI</i>: 0.75 to 0.85) in the training set, 0.73 (95%<i> CI</i>: 0.68 to 0.78) in the internal validation set, and 0.60 (95%<i> CI</i>: 0.55 to 0.65) in the external validation set. Among radiomics models, the multiparametric radiomics model (T2WI + DWI + CE-T1WI) achieved optimal performance, with AUCs of 0.98 (95% <i>CI</i>: 0.95 to 1.00), 0.95 (95% <i>CI</i>: 0.91 to 0.99), 0.86 (95% <i>CI</i>: 0.81 to 0.91) in the training, internal validation, and external validation sets, respectively. The nomogram model achieved the best predictive performance. The AUC, accuracy, sensitivity, and specificity of the training set of nomogram model were 0.99 (95% <i>CI</i>: 0.97 to 1.00), 98%, 95%, and 98%, respectively. The internal validation sets were 0.98 (95% <i>CI</i>: 0.95 to 1.00), 98%, 98% and 98%, respectively. The external validation sets were 0.88 (95% <i>CI</i>: 0.83 to 0.93), 88%, 87% and 87% respectively. DeLong test indicated that the nomogram model<sup><sup>,</sup></sup>s performance was superior to the clinical model and the radiomics models (<i>P</i> &lt; 0.05). Shapley analysis revealed that wavelet-LHL_glszm_SmallAreaEmphasis in DWI sequence was the most important feature in the radiomics model. <b>Conclusions</b>The nomogram based on multiparametric MRI radiomics and clinical-radiology features may be used as an accurate and non-invasive method to predict the efficacy of nCRT in rectal cancer patients, and the Shapley algorithm can provide interpretability of radiomics model. This nomogram has been validated using an external validation set, suggesting its potential utility of providing important guidance for clinical diagnosis and treatment decision-making. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Interpretable machine learning model based on DCE-MRI habitat imaging radiomics for predicting lymph node metastasis in rectal cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.010</link>
<description><![CDATA[<b>Objective</b>To construct an interpretable integrated model based on dynamic contrast-enhanced MRI (DCE-MRI) habitat imaging radiomics and clinical features, and to assess its utility in predicting lymph node metastasis (LNM) status in rectal cancer. <b>Materials and Methods</b>A retrospective analysis was conducted on the clinicopathological and imaging data of 148 patients with rectal cancer admitted to Gansu Provincial People<sup><sup>,</sup></sup>s Hospital between January 2016 and July 2024. Patients were stratified into LNM-positive and LNM-negative groups based on postoperative pathological confirmation. They were then randomly divided into a training cohort (<i>n </i>= 103) and a test cohort (<i>n</i> = 45) in a 7∶3 ratio. The region of interest (ROI) was manually delineated on the DCE-MRI parametric map using ITK-SNAP software. Subsequently, 19 standardized radiomics features were extracted from the K<sup>trans</sup> maps. K-means clustering (K = 4) was applied to partition the tumor into distinct habitat subregions. Radiomics features were extracted separately from each tumor subregion (habitat-specific features) and from the whole tumor volume (whole-tumor features). The intra-class correlation coefficient (ICC) was calculated to assess the reproducibility of the whole-tumor radiomics feature extraction. Feature selection involved Z-score normalization, correlation analysis, and the least absolute shrinkage and selection operator (LASSO) algorithm. Predictive models for LNM status were developed using four machine learning classifiers: extremely randomized trees, logistic regression, random forest, and support vector machine. These models were built based on habitat-specific radiomics features and whole-tumor radiomics features separately. Logistic regression was also used to identify independent clinical predictors and construct a clinical model. Finally, an integrated model was built by combining significant clinical predictors with the radiomics signature derived from the habitat analysis. Model performance was evaluated using the receiver operating characteristic (ROC) curve and quantified by the area under the curve (AUC). Decision curve analysis (DCA) was performed to assess the clinical utility of the models. The importance of features in the final integrated model was determined, and the model<sup><sup>,</sup></sup>s predictions were explained visually using Shapley additive explanations (SHAP) analysis. <b>Result</b>Univariate analysis identified carcinoembryonic antigen (CEA) level and MRI-reported N-stage as significant predictors of lymph node status in the training cohort [odds ratios (OR) = 2.346 and 7.727, respectively; 95% confidence intervals (<i>CI</i>): 1.052 to 5.233 and 2.273 to 26.268, respectively; <i>P</i> &lt; 0.05]. The predictive model based on habitat radiomics features demonstrated superior performance, with AUC values of 0.890 (training cohort) and 0.801 (test cohort), outperforming the whole-tumor radiomics model (AUC: 0.774 training, 0.684 test). The integrated model, combining clinical features with the habitat radiomics signature, achieved the highest AUC values: 0.896 in the training cohort and 0.866 in the test cohort. DCA indicated that the integrated model provided a higher net clinical benefit across a range of threshold probabilities. SHAP analysis provided quantitative interpretability for the integrated model<sup><sup>,</sup></sup>s predictions, revealing the habitat radiomics score as the most significant predictor. <b>Conclusions</b>The interpretable integrated model, constructed using preoperative DCE-MRI habitat imaging radiomics features and clinical factors, accurately predicts lymph node status in rectal cancer patients. By providing visual interpretation of individual predictions through SHAP, this model offers a valuable tool to support personalized treatment decision-making. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Prediction of lymph node metastasis in cervical cancer using virtual magnetic resonance elastography]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.011</link>
<description><![CDATA[<b>Objective</b>To evaluate the predictive efficacy of virtual magnetic resonance elastography (vMRE) based on diffusion-weighted imaging (DWI) for lymph node metastasis (LNM) in cervical cancer patients undergoing direct surgery. <b>Materials and Methods</b>Clinical and imaging data of cervical cancer patients who underwent preoperative pelvic MRI and radical hysterectomy at Henan Provincial People<sup><sup>,</sup></sup>s Hospital between November 2021 and November 2022 were retrospectively collected and analyzed. The pelvic MRI protocol included multi-b-value DWI, and vMRE images were generated from DWI data to extract the (μ<sub>Diff</sub>) parameter. Based on postoperative pathology, patients were divided into LNM-positive and LNM-negative groups. The <i>t</i>-test or Mann-Whitney <i>U</i> test was used to compare differences in DWI-based virtual shear modulus μ<sub>Diff</sub> parameters between groups, and logistic regression analysis was performed to identify variables associated with lymph node status. Predictive models were constructed, and receiver operating characteristic (ROC) curves were plotted. The area under the curve (AUC) was used to evaluate the predictive performance of each model. <b>Results</b>Among clinical variables, squamous cell carcinoma antigen (SCCAG) and maximum lymph node short-axis diameter were significantly associated with LNM. The mean, maximum, and median μ<sub>Diff</sub> values in the LNM-positive group were significantly higher than those in the negative group (<i>P</i> &lt; 0.05). The combined model incorporating the maximum μ<sub>Diff</sub> value and maximum lymph node short-axis diameter demonstrated the best predictive performance for LNM, with an AUC of 0.824 (95% <i>CI</i>: 0.683 to 0.965), superior to the single model constructed solely based on the mean μ<sub>Diff</sub> value and the short-axis diameter of the largest lymph node. <b>Conclusions</b>vMRE image features based on multi-b-value DWI can serve as a noninvasive indicator reflecting tissue stiffness, improving the predictive accuracy of LNM in cervical cancer patients. This approach provides a novel imaging biomarker for the preoperative noninvasive assessment of LNM. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Conventional clinicopathological features combined with MRI-based radiomics model for predicting programmed death-ligand 1 expression]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.012</link>
<description><![CDATA[<b>Objective</b>To establish a combined model based on MRI-based radiomics features and clinicopathological characteristics for evaluating the programmed death-ligand 1 (PD-L1) level in cervical cancer. <b>Materials and Methods</b>A retrospective analysis was conducted on 327 cervical cancer patients who underwent MR enhanced scans at Liaoning Cancer Hospital &amp; Institute, from January 2021 to September 2024. The samples were randomly divided into a training set (<i>n</i> = 228) and a validation set (<i>n</i> = 99) in a 7∶3 ratio. The PD-L1 combined positive score (CPS) ≥ 10 was used as the cut-off value and divided the patients into high and low expression groups. Radiomics feature selection was generated through the <i>χ</i><sup>2</sup> test, the analysis of variance and random forest. An extreme gradient boosting (XGBoost) classifier was employed for model construction. Univariate logistic regression analysis was used to analyze the clinicopathological data. Radiomics modesl, clinicopathological models and combined models were developed for predicting the level of PD-L1. The predictive performance of the model was evaluated using the receiver operating characteristic (ROC) curve, calibration curve and decision curve analysis (DCA). <b>Results</b>There were significant differences in human papillomavirus (HPV) infection and degree of differentiation between the high and low PD-L1 cervical cancer expression groups (all <i>P</i> &lt; 0.05). The AUC of the clinical model in the training and validation sets were 0.672 [95% confidence interval (<i>CI</i>): 0.598 to 0.745] and 0.698 (95% <i>CI</i>: 0.578 to 0.819), respectively. Seven radiomics features were selected from 2261 extracted radiomics features to construct the model, and the AUC was 0.788 (95% <i>CI</i>: 0.728 to 0.848) and 0.712 (95% <i>CI</i>: 0.593 to 0.832) in the training and validation sets, respectively. The AUC of the combined model in the training and validation sets were 0.932 (95% <i>CI</i>: 0.898 to 0.967) and 0.805 (95% <i>CI</i>: 0.694 to 0.916), respectively. <b>Conclusions</b>PD-L1 expression can be effectively predicted using an MRI-based radiomics model combined with clinicopathological characteristics to identify patients who may benefit from anti-PD-L1 immunotherapy. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Prognostic value of an MRI-based radiomics machine learning model for patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.013</link>
<description><![CDATA[<b>Objective</b>To construct a machine learning model for predicting the prognosis of concurrent chemoradiotherapy (CCRT) in patients with locally advanced cervical cancer (LACC) based on magnetic resonance imaging (MRI) radiomics features, and to evaluate its predictive performance. <b>Materials and Methods</b>A retrospective analysis was performed on 424 LACC patients admitted to the Affiliated Cancer Hospital of Xinjiang Medical University from February 2019 to February 2020. Patients were randomly assigned to a modeling group (<i>n </i>= 339) and an internal validation group (<i>n </i>= 85) at a 4∶1 ratio. Additionally, 120 LACC patients admitted to the Second Affiliated Hospital of Xinjiang Medical University during the same period were enrolled as the external validation group. Clinical data and MRI images (including transverse dynamic contrast-enhanced T1WI, transverse fast spin echo T2WI, and transverse diffusion-weighted imaging sequences) were collected. The region of interest (ROI) was delineated in the lesion area, and radiomics features were extracted using PyRadiomics. Dimensionality reduction and selection of radiomics features were conducted via the least absolute shrinkage and selection operator (LASSO) algorithm. A radiomics model was constructed based on the selected features, and radiomics scores (Rads) were calculated. Cox univariate and multivariate analyses were performed using patient clinical data and Rads to establish a prognostic prediction model for CCRT in LACC patients, followed by validation of the model<sup><sup>,</sup></sup>s predictive performance. <b>Results</b>Thirteen MRI radiomics features were selected by the LASSO algorithm. Univariate and multivariate Cox analyses demonstrated that external beam radiotherapy dose [hazard ratio (HR) = 1.275, 95% <i>CI</i>: 1.186 to 1.371] and 2 Gy fractionated radiation equivalent dose (HR = 1.092, 95% <i>CI</i>: 1.050 to 1.137) were independent risk factors for mortality following CCRT in LACC patients, whereas hemoglobin (HR = 0.962, 95% <i>CI</i>: 0.940 to 0.985) and Rads (HR = 0.949, 95% <i>CI</i>: 0.933 to 0.965) were protective factors (all <i>P </i>&lt; 0.05). Model validation showed that the area under the curve (AUC) values for internal and external validation were 0.978 (95% <i>CI</i>: 0.965 to 1.000) and 0.971 (95% <i>CI</i>: 0.958 to 0.996), respectively. The Hosmer-Lemeshow test yielded chi-square values of 8.580 (<i>P </i>= 0.379) and 8.691 (<i>P </i>= 0.370) for internal and external validation, respectively. <b>Conclusions</b>This study established a nomogram prediction model based on MRI radiomics, which exhibits excellent predictive performance and clinical utility for the prognosis of CCRT in LACC patients. It may serve as a reference for the formulation and adjustment of CCRT treatment plans for LACC patients. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A prenatal MRI signs- clinical scoring system to predict the classifications of placenta accreta spectrum]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.014</link>
<description><![CDATA[<b>Objective</b>To establish a prenatal MRI-clinical scoring system and to explore its predictive value for the classifications of placenta accreta spectrum (PAS). <b>Materials and Methods</b>We retrospectively collected the clinical and imaging data of pregnant women who visited the obstetrics clinic of our hospital and were suspected of PAS based on ultrasound or clinical screening, from January 2018 to June 2023. PAS disorders were diagnosed and classified by the surgical and pathological examinations. According to the updated joint consensus of the American Society of Abdominal Radiology and the European Society of Urogenital Radiology, 11 MRI signs related to PAS were selected. The clinical independent risk factors for PAS were selected by univariate and multivariate logistic regression. The logistic regression analysis combining independent risk factors and all MRI signs was used to screen the features with <i>P</i> &lt; 0.05. The weighting of each feature was calculated based on its <i>β</i> coefficient. The receiver operating characteristic (ROC) curve was used to evaluate the predictive performance of the scoring system, and the threshold of the score for each classification, area under the curve (AUC), sensitivity, specificity, and other diagnostic indicators were calculated. <b>Results</b>A total of 404 pregnant women who met the inclusion and exclusion criteria were collected. Seven features based on MRI and clinics were included in our scoring system. For the comparison between the non-PAS and PA groups, the cut-off value was 6.0. The optimal cut-off value between PA and PI groups was 11.0. The threshold value for PI and PP groups was 17.0. <b>Conclusions</b>The prenatal MRI signs-clinical scoring system possesses favorable clinical feasibility. It plays an important role for assisting in the diagnosis of PAS disorders and identifying the high-risk patients. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The diagnostic value of radiomics features of the lateral pterygoid muscle, articular disc, and bilaminar zone on MRI in temporomandibular disorders]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.015</link>
<description><![CDATA[<b>Objective</b>To investigate the radiomic features of the lateral pterygoid muscle, articular disc, and bilaminar zone (retrodiscal tissue) on magnetic resonance imaging (MRI) in patients with temporomandibular disorder (TMD). The study aims to facilitate the early diagnosis and differential diagnosis of TMD subtypes, thereby enhancing clinical efficiency. <b>Materials and Methods</b>This retrospective study included imaging and clinical data from patients clinically diagnosed with TMD at the First Affiliated Hospital of University of Science and Technology of China between December 2019 and October 2024. A total of 121 patients were enrolled. Data from each joint side were analyzed independently, resulting in three groups: 33 sides with reducible disc displacement (RDD), 89 sides with non-reducible disc displacement (NRDD), and 120 sides without disc displacement (ND). Radiomic features were extracted from the lateral pterygoid muscle, articular disc, and bilaminar zone. Univariate analysis of variance (ANOVA) with Bonferroni correction was employed to identify features with significant differences among the three groups. Subsequently, a "One-vs-Rest" (OVR) strategy was used to train logistic regression models, with the selected significant features as inputs and the predicted probabilities for each group as outputs. Three predictive models were developed: a clinical model, a radiomics model, and a combined model (integrating both clinical and radiomic features), using univariate and multivariate logistic regression analyses. The training set was partitioned using stratified random sampling, and the diagnostic performance was evaluated on the testing set. After performing stratified 5-fold cross-validation, the model performance was evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. The DeLong test was used to assess the statistical significance of differences between AUCs, and decision curve analysis (DCA) was conducted to evaluate the predictive net benefit of the models. <b>Results</b>(1) Seven radiomic features from the bilaminar zone and five from the articular disc were identified as significantly different among the three groups. No significant features were found in the lateral pterygoid muscle, suggesting limited radiomic differences in this muscle across TMD subtypes. (2) The ROC curve analysis demonstrated that the significant features from the articular disc achieved high diagnostic performance in distinguishing between NRDD (AUC = 0.79) and ND (AUC = 0.78). The significant features from the bilaminar zone showed high efficacy in identifying ND (AUC = 0.84). (3) All statistical tests were two-sided, with the significance level set at 0.05. Evaluation on the testing set revealed that the combined model (AUC = 0.90) exhibited significantly stronger and more stable discriminatory power, as well as superior predictive and diagnostic efficacy, compared to the clinical model (AUC = 0.88) and the radiomics model (AUC = 0.78). <b>Conclusions</b>While radiomic analysis of the lateral pterygoid muscle alone is insufficient for TMD subtype differentiation, our study establishes that MRI-based radiomics of the articular disc and bilaminar zone provides a novel paradigm for early diagnosis, differential diagnosis, and guiding clinical interventions in TMD. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[T1-weighted signal intensity changes in the dentate nucleus after multiple gadolinium-enhanced MRI: A clinical study]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.016</link>
<description><![CDATA[<b>Objective</b>To investigate changes in signal intensity (SI) of the dentate nucleus (DN) on unenhanced T1-weighted magnetic resonance imaging (MRI) scans after multiple administrations of linear gadolinium-based contrast agents (GBCAs), and to analyze its correlation with various clinical factors. <b>Meterials and </b>Methods: Clinical and imaging data of ninety-two patients who underwent at least three consecutive linear GBCA-enhanced MRI examinations at our hospital from January 2015 to December 2024 were analyzed retrospectively. Unenhanced MRI scans were performed before and after consecutive enhanced MRI examinations in all patients. On a post-processing workstation, the mean SI of the DN and the pons were measured on unenhanced T1-weighted images. The SI ration of DN-to-pons was calculated by dividing the SI in the DN by that in the pons. A generalized additive model (GAM) was used to examine the trends and patterns of the SI ratio of DN-to-pons relative to the number of GBCAs administrations. Linear regression analysis was used to examine SI ratio of DN-to-pons correlation with various clinical factors. The incremental changes in the SI ratio of DN-to-pons between consecutive examinations were compared to analyze their trend and a trend analysis was used on the variation pattern. <b>Results</b>The SI ratio of DN-to-pons increased with the cumulative number of linear GBCAs injections, following a non-linear pattern. The SI ratio differences showed a significant correlation with the number of injections (<i>P </i>&lt; 0.001). There was no correlation with other clinical factors (<i>P </i>&gt; 0.05). Analysis of the incremental changes in the ratio after the first 6 enhancements revealed median increments of 1.91, 0.94, 0.93, 0.88, 0.91, and 0.87. A trend test was performed on the incremental changes, revealing statistically significant differences (coefficient of the linear mixed-effects model: -0.215,<i> P</i> &lt; 0.001; coefficient of the polynomial trend analysis: -7.530, <i>P</i> &lt; 0.001). <b>Conclusions</b>Serial injections of linear GBCAs may lead to a non-linear increase in SI in the DN,which correlates with the number of contrast-enhanced examinations, while the rate of increase gradually slows down as the number of such examinations rises. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in magnetic resonance imaging of fetal brain development]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.019</link>
<description><![CDATA[Fetal magnetic resonance imaging (MRI) is an advanced prenatal imaging diagnostic technology. Beyond the scope of traditional anatomical examinations, it enables non-invasive assessment of in utero metabolic and functional development of the fetal brain and other organs. With the rapid advancement of magnetic resonance technology, fetal functional MRI is expected to become a powerful method for understanding fetal development and early identification of neurological abnormalities and other fetal diseases. At present, the research on fetal magnetic resonance imaging in China mainly focuses on the assessment of normal fetal nervous system development and the study of brain structure in malformed fetuses. However, there is a lack of research on the trajectory of fetal brain functional development, prediction of birth outcomes, and neurobehavioral abilities. This article mainly discusses the progress in magnetic resonance research on fetal brain venous development, metabolism, microstructure, and functional connectivity, and points out the future research directions. This review will provide new methods for evaluating the normal brain development pattern of the fetus and early detection of fetal brain development abnormalities. By observing changes in brain function and metabolic activity, abnormal metabolism and neural signals can be identified, providing a basis for early diagnosis and postnatal treatment of diseases. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on multimodal structural-functional MRI studies of hierarchical large-scale brain network abnormalities in autism spectrum disorder]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.020</link>
<description><![CDATA[Autism spectrum disorder (ASD) is a neurodevelopmental condition that emerges in early childhood, characterized by social communication difficulties and restricted, repetitive behaviors. Despite their diverse symptoms, individuals with ASD may have shared neurobiological characteristics. Advances in MRI now allow researchers to study brain network abnormalities in ASD from multiple, noninvasive perspectives. This review highlights recent studies using diffusion and functional MRI, covering tract-based spatial statistics, graph theory analyses, functional gradient mapping, and sliding-window approaches. We focus on how these methods help reveal white matter integrity, functional coordination, and hierarchical brain organization in ASD. We also discuss the potential of multimodal image fusion and artificial intelligence (AI) for ASD subtype identification and auxiliary diagnosis. Overall, findings from multimodal MRI indicate cross-scale alterations of brain networks in ASD, providing new imaging evidence for understanding its neural mechanisms and for supporting early identification and individualized intervention. On this basis, we briefly outline the main limitations of current research and, from an integrated perspective spanning "microstructure-large-scale function-structure-function coupling-multimodal analysis", propose future research directions to inform radiologists and neuroscience researchers. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of magnetic resonance diffusion kurtosis imaging on the microstructure of white matter in patients with major depressive disorder]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.021</link>
<description><![CDATA[Depression is a severe mental disorder characterized by persistent low mood, loss of interest and anhedonia, accompanied by abnormal cognitive, behavioral and physiological functions. In severe cases, suicidal thoughts or behaviors may occur. The global prevalence rate is approximately 5%, resulting in a heavy socio-economic burden. Diffusion kurtosis imaging is a non-Gaussian diffusion technique based on water molecules, which can demonstrate the high heterogeneity of water molecule diffusion limitations and better study the white matter properties of complex fibrous regions, thereby obtaining the morphological parameters of nerve fibers. At present, most research on depression focuses on diffusion tensor imaging or brain gray matter, making it difficult to fully summarize the current research progress. This article mainly studies the correlation between the parameter values of diffusion kurtosis imaging and the changes in white matter of the brain and clinical symptoms in depression, and proposes future research directions,aimed at providing imaging evidence for the early diagnosis, disease monitoring and optimization of treatment plans of depression. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of abnormal gBOLD-CSF coupling in brain glymphatic system related central nervous system diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.022</link>
<description><![CDATA[The glymphatic system (GS) is a waste clearance pathway in the brain, and its impaired function is closely associated with various central nervous system diseases. Resting-state functional magnetic resonance imaging (rs-fMRI) studies have revealed that low-frequency (&lt; 0.1 Hz) global blood oxygen level-dependent (gBOLD) signals are coupled with cerebrospinal fluid (CSF) dynamics, a phenomenon that is related to GS function and provides a new direction for uncovering brain glymphatic dysfunction. This review summarizes the key aspects of the GS, the principles of gBOLD-CSF coupling, and its applications in central nervous system diseases. It aims to synthesize research on GS functional changes in a range of central nervous system disorders, and to clarify the value and prospects of abnormal gBOLD-CSF coupling for assessing disease severity and evaluating treatment efficacy. Meanwhile, this review identifies the limitations of current research and proposes directions for future studies. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in imaging research on the correlation between cerebral small vessel disease-related white matter hyperintensities and cognitive impairment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.023</link>
<description><![CDATA[White matter hyperintensities (WMH) are a typical imaging hallmark of cerebral small vessel disease (CSVD). Early-stage WMH may reflect reversible injuries, such as interstitial fluid circulation disorders, whereas advanced WMH indicate permanent lesions like demyelination and axonal loss. CSVD-related WMH are closely correlated with the progression of cognitive impairment. This correlation is manifested not only in the impacts of total WMH burden and spatial distribution on cognitive function, but also in the significant association between WMH and abnormalities in brain microstructure and function. Therefore, WMH may serve as an important imaging mediator for CSVD-related cognitive impairment induced by brain microstructural and functional abnormalities. This review focuses on the pathophysiological mechanisms of CSVD-related WMH, their direct correlation with cognitive impairment, and recent advances in imaging research regarding their multiple associations with underlying brain microstructural and functional injuries of cognitive impairment. The aim is to deepen the understanding of the role and significance of WMH, a core imaging sign of CSVD, in the clinical assessment of CSVD-related cognitive impairment, and to provide objective evidence for further research, diagnosis, and treatment of this condition. Furthermore, this review identifies the limitations in the current research and proposes potential avenues for future investigation. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on magnetic resonance imaging of memory decline caused by cerebral small vessel disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.024</link>
<description><![CDATA[Cerebral small vessel disease (CSVD) is one of the leading causes of vascular cognitive impairment (VCI) and dementia, in which memory impairment represents a core clinical manifestation. With the widespread application of high-resolution multimodal magnetic resonance imaging (MRI), researchers are now able to more precisely elucidate the neural mechanisms by which CSVD lesions involve key memory-related regions such as the hippocampus, medial temporal lobe, and thalamus, thereby leading to memory dysfunction. While research in this area has progressed rapidly, the understanding of its specific mechanisms remains controversial, and the translation of imaging biomarkers into clinical practice remains immature. Therefore, it is necessary to conduct a systematic review and synthesis of the current evidence. This article summarizes recent neuroimaging studies on CSVD-related memory decline, outlining the pathophysiological mechanisms through which CSVD affects memory function and the clinical value of various imaging biomarkers. At the same time, it highlights the limitations of current mechanistic research and the challenges faced in translating imaging biomarkers into clinical practice, and proposes perspectives for future research. The aim of this review is to systematically collate the imaging evidence for memory impairment in CSVD, thereby providing an imaging basis for early diagnosis, precision intervention, and treatment response evaluation, and ultimately offering useful references for clinical practice. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in the application of diffusion tensor imaging combined with artificial intelligence in cerebral small vessel disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.025</link>
<description><![CDATA[Cerebral small vessel disease (CSVD) is one of the most important causes of vascular cognitive impairment and recurrent stroke. It has an insidious onset, and conventional MRI often appears normal in the early stages, making it difficult to detect occult white matter microstructural damage, which frequently leads to delayed optimal intervention. Diffusion tensor imaging (DTI), through its core parameters such as fractional anisotropy, mean diffusivity, and derived metrics (e.g., diffusion tensor imaging analysis along perivascular spaces, peak width of skeletonized mean diffusivity, free water, etc.), can sensitively detect demyelination, microscopic edema, and glymphatic system dysfunction even when conventional MRI sequences show no obvious abnormalities. It has become the most important and sensitive noninvasive technique for assessing CSVD. This systematic review summarizes the imaging principles of DTI, as well as the latest applications of its core and derived parameters in the full spectrum of CSVD. It emphasizes the clinical value of DTI in early diagnosis, pathological mechanism elucidation, subtype differentiation, cognitive impairment prediction, and prognosis assessment. The limitations of current research are identified, and future research directions are proposed by integrating the research trends of artificial intelligence (AI) and multimodal image fusion. The aim is to provide clinicians and radiologists with a comprehensive understanding of the role of DTI combined with AI in CSVD evaluation and to offer insights for subsequent research. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of convolutional neural network and vision transformer in gliomas]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.026</link>
<description><![CDATA[Gliomas pose significant challenges to traditional diagnosis and treatment due to their high heterogeneity, strong invasiveness, and poor prognosis. The introduction of deep learning (DL) technology has opened up a new avenue for their precise diagnosis and treatment, among which convolutional neural network (CNN) and Vision Transformer (ViT) are core tools. CNN inherently excels in local feature extraction (e.g., tumor edges, texture details) through hierarchical convolution operations, while ViT stands out in global context modeling (e.g., cross-regional heterogeneity of tumors, multimodal correlations) based on the self-attention mechanism. The fusion strategy of CNN and ViT integrates local fine-grained features with global associated information, demonstrating remarkable advantages in addressing clinical dilemmas such as blurred glioma boundaries and cross-modal data heterogeneity. This article reviews the research progress of CNN and ViT in key clinical tasks of gliomas, including detection and segmentation, pathological grading, molecular subtyping, and prognosis assessment. It elaborates on their principles, individual applications, and fusion strategies. Furthermore, it discusses the prevailing challenges in the field, such as the heavy reliance on annotated data and insufficient model interpretability, and outlines promising future research directions, including the development of lightweight architectures, the advancement of self-supervised learning paradigms, and the promotion of multi-omics integration. This review thereby provides a systematic reference for the intelligent diagnosis of gliomas. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress in multimodal MRI radiomics for predicting molecular typing of gliomas]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.027</link>
<description><![CDATA[Glioma, as the most common primary malignant tumor in the central nervous system (CNS), is characterized by high heterogeneity. Accurate molecular subtyping is conducive to formulating treatment strategies and improving prognosis for glioma patients. Although glioma can be diagnosed through surgical procedures or biopsies, such methods are invasive, carrying risks of sampling bias and postoperative complications. Multimodal MRI radiomics, a prominent area of research in disease diagnosis, is capable of integrating the strengths of various MRI imaging techniques. By extracting high-throughput imaging features spanning morphology, texture, functional metabolism and other dimensions, and leveraging machine learning, deep learning as well as statistical analysis tools to build predictive models, this technique has demonstrated significant potential for non-invasive assessment of glioma molecular markers. This paper reviews the recent advances in multimodal MRI radiomics for non-invasively predicting glioma molecular subtypes, points out current research limitations, and suggests future research directions, with the aim of ultimately providing imaging evidence and clinical guidance for preoperative precise diagnosis and the formulation of personalized treatment regimens for glioma patents. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in artificial intelligence for MRI of carotid artery vulnerable plaques​]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.028</link>
<description><![CDATA[Ischemic stroke has high incidence, high disability rate, and high mortality rate. Globally, approximately 18% to 30% of ischemic stroke events are attributable to thromboembolism caused by ruptured carotid vulnerable plaques. However, the precise identification of carotid vulnerable plaques in current clinical practice faces significant challenges, as traditional imaging techniques have limitations in insufficient sensitivity. Multi-parameter magnetic resonance imaging (MRI), with its high soft-tissue contrast, serves as the gold standard for assessing plaque vulnerability, yet manual analysis has limitations such as large inter-observer differences and insufficient characterization of feature correlations. This article reviews research advances in artificial intelligence (AI) technology for MRI evaluation of carotid vulnerable plaques from the following aspects: innovations in automated plaque segmentation and quantitative analysis algorithms, deep learning-based predictive models for vulnerability biomarkers, and intelligent methods for clinical outcome assessment and treatment response prediction. The limitations of the current research are clarified, and potential directions for future investigations are proposed. This study deeply integrates the potential of AI technologies to accelerate their clinical translation in the identification of carotid vulnerable plaques, thereby enhancing the detection efficiency of vulnerable plaques and facilitating the early prevention and treatment of ischemic stroke. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress in predicting axillary lymph node metastasis in breast cancer using dynamic contrast-enhanced magnetic resonance imaging-based radiomics]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.029</link>
<description><![CDATA[Breast cancer is a leading cause of cancer-related death among women worldwide, and the presence of axillary lymph node metastasis (ALNM) is a critical determinant of both patient prognosis and therapeutic strategy. Invasive diagnostic methods like sentinel lymph node biopsy (SLNB) carry risks of complications and false-negative results, creating a pressing clinical need for developing accurate, non-invasive preoperative assessment tools. Radiomics provides a novel technical approach for decoding tumor heterogeneity and predicting ALNM by high-throughput extraction and analysis of medical imaging features. Among these, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)-based radiomics has become a research focus in predicting ALNM in breast cancer and demonstrates promising application potential. However, there remains a lack of systematic reviews in this field, which has to some extent constrained the standardized development of non‑invasive assessment techniques for ALN in breast cancer and their translation into clinical practice. This article systematically outlines the three developmental stages of DCE-MRI radiomics in predicting ALNM (feasibility validation of models, exploration of the value of the peritumoral region, and construction of multiparameter fusion models) while also providing an in-depth analysis of the standardization challenges faced by this field and proposing future research directions. The aim is to offer evidence-based support and clinical references for researchers and radiologists, with the goal of enhancing the precision of individualized diagnosis and treatment for breast cancer patients. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application Progress of MRI Histogram Analysis in Endometrial Cancer and Cervical Cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.030</link>
<description><![CDATA[Endometrial carcinoma (EC) and cervical carcinoma (CC) are two common gynecological malignancies, with incidence and mortality rates increasing year by year. And in recent years they have tended to occur in younger patients. Early detection and timely treatment are crucial for improving patient survival and preserving fertility. Conventional MRI serves as the primary imaging modality for preoperative assessment, treatment monitoring, and prognostic evaluation in EC and CC. It holds significant value in the morphological assessment of tumors. However, its capability for quantitatively evaluating tumor heterogeneity and microscopic pathological features remains relatively limited. MRI histogram analysis is an image processing technique based on pixel distribution, which can provide more quantitative information and can reflect the biological characteristics of tumors more objectively and comprehensively. Currently there are fewer research reviews about histogram analysis of different MRI parameters in EC and CC, which lacks a systematic and comprehensive combing and in-depth analysis. Therefore, this paper summarizes the research progress of histogram analysis of various MRI parameters in the diagnosis, staging, histopathological features, efficacy and prognosis assessment of EC and CC. We also analysis the current challenges and look forward to the future direction of the research, in order to provide new ideas for future research. We conclude that there are critical challenges in the current research: insufficient standardization of research methods, single-center small-sample designs and insufficient multimodal image-clinical phenotype correlation models, resulting in limited stability of histogram features. In the future, it is necessary to develop an assessment system that integrates multimodal MRI, multicenter large-sample data and artificial intelligence-enhanced MRI histogram technology, with the aim of promoting intelligent diagnosis and treatment of EC and CC with imaging. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The assessment method for skeletal muscle fat infiltration: quantitative magnetic resonance imaging]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.031</link>
<description><![CDATA[Fat infiltration (FI) in skeletal muscles is extensively involved in the pathological progression of various diseases. Accurately assessing the degree of muscle fat infiltration is of paramount importance for formulating effective treatment plans and intervening in disease progression. Radiological parameters for quantifying fat infiltration, particularly those derived from quantitative magnetic resonance imaging (qMRI) technology, have demonstrated significant potential as diagnostic elements for diseases and predictive tools for metabolic risks. This article primarily focuses on introducing the advantages and limitations of qMRI techniques, including chemical shift encoding magnetic resonance imaging (CSE-MRI), magnetic resonance spectroscopy (MRS), T1/T2 mapping, and texture analysis, as well as their clinical applications in the diagnosis and monitoring of diseases such as muscular dystrophy, metabolic diseases, and degenerative conditions associated with osteoarthritis. Studies have shown that qMRI technology can precisely quantify muscle fat infiltration and holds promise as an important non-invasive diagnostic tool in the field of muscle pathology. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Principles and clinical application advances of virtual magnetic resonance elastography based on DWI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.032</link>
<description><![CDATA[virtual magnetic resonance elastography (vMRE) is an emerging technology based on diffusion-weighted imaging (DWI) that noninvasively assesses tissue stiffness by estimating virtual shear modulus through water molecule diffusion. Tissue mechanical properties are closely associated with various diseases such as liver fibrosis and tumor infiltration. However, traditional magnetic resonance elastography relies on specialized vibration devices, limiting its clinical adoption. Recent studies indicate that DWI-vMRE holds diagnostic value in liver fibrosis, intracranial tumors, and lesions in organs such as the breast and lungs, enabling quantitative assessment of tissue mechanical properties without specialized hardware. However, existing research primarily consists of small-sample, single-center studies, with inconsistent models and scanning protocols, and a lack of systematic reviews and standardized guidelines. This paper comprehensively reviews the physical principles, parameter calculation methods, and common scanning strategies of vMRE. It summarizes its application progress in multiple systemic diseases, identifies key limitations such as model assumptions, confounding factors, and reproducibility of results, and explores future research directions integrating vMRE with multimodal MRI and artificial intelligence technologies. This review aims to provide insights for subsequent basic and clinical research and serve as a reference for noninvasive imaging assessment of soft tissue stiffness. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress in clinical applications of MRI based on electromagnetic metamaterials]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.033</link>
<description><![CDATA[As an emerging technology, electromagnetic metamaterials can optimize MRI imaging performance without modifying the system hardware, while balancing safety and flexibility. Over the past two decades, electromagnetic metamaterials have achieved breakthrough progress in directions such as lightweighting, flexibility, and self-tuning, attracting increasing attention. However, most current studies only focus on some of their technical advantages in MRI, without incorporating comprehensive performance indicators. This makes it difficult to form a systematic understanding of the clinical application value of electromagnetic metamaterials, thus failing to provide adaptive references for multi-site diagnosis and treatment scenarios. This paper reviews the material properties and electromagnetic characterization of electromagnetic metamaterials, as well as their significant advantages in improving the local signal-to-noise ratio and resolution of MRI images, reducing specific absorption rate, enhancing radiofrequency field uniformity and magnetic field penetration depth, and supporting multi-nuclear imaging. It covers the latest research on anatomical sites including the head, heart, breast, abdomen, and limb joints. Additionally, this paper analyzes the limitations of current research, proposes future research directions, and provides a reference framework for the clinical application of electromagnetic metamaterials. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in time-dependent diffusion MRI for noninvasive prediction of tumor molecular biomarkers]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.034</link>
<description><![CDATA[Time-dependent diffusion MRI (TDD-MRI) is an emerging noninvasive imaging technique with a unique capability for the quantitative interrogation of tissue and cellular microstructure. Pathological alterations in tumors are frequently accompanied by abnormalities in cellular microarchitecture, whereas conventional clinical assessments of tumor molecular biomarkers still largely depend on invasive procedures, which are limited by poor timeliness and difficulties in dynamic or longitudinal monitoring. The advent of TDD-MRI provides new opportunities for the noninvasive and in vivo evaluation of molecular biomarkers. Current studies suggest that TDD-MRI shows considerable potential in the assessment of tumor molecular biomarkers and may enable the characterization of differences in molecular mechanisms within the tumor microenvironment. However, TDD-MRI remains at an early stage of development. Major challenges include the absence of a standardized framework for parameter definitions, a lack of unified acquisition and analysis protocols, and insufficient integration with multimodal approaches such as radiomics. In this review, we systematically summarize recent advances in the application of TDD-MRI to tumor molecular biomarker evaluation, identify shared characteristics observed across studies within the same cancer type, and further analyze the sources of inter-study differences from the perspectives of parameter-specific mechanisms, tumor heterogeneity, and cross-cancer features. Finally, we delineate the limitations of current research and propose future directions to facilitate methodological standardization, expand cross-cancer applications, and promote clinical translation, thereby supporting the development of precision oncology. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Multinuclear magnetic resonance imaging in oncology: research progress]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.01.035</link>
<description><![CDATA[Magnetic resonance imaging (MRI), which is recognized for its high spatial resolution, excellent soft-tissue contrast, and absence of ionizing radiation, has become an essential tool in tumor diagnosis, staging, classification, treatment response evaluation, and prognosis assessment. As oncology diagnostics and therapeutics advance toward precision medicine, MRI technology is progressively evolving from macroscopic structural and functional imaging toward imaging at the microscopic cellular and metabolic levels. Multinuclear magnetic resonance can detect not only hydrogen (¹H)-the most abundant nucleus in the human body, but also other nuclei, such as phosphorus (³¹P), sodium (²³Na), and xenon (¹²⁹Xe), thereby overcoming the limitations of conventional single-nucleus MRI. This technique provides a novel approach and perspective into tumor characterization and management by integrating structural, functional, and metabolic information. This review systematically summarizes recent advances in multinuclear MRI (multi-NMR) for oncology applications, highlights its potential in elucidating tumor metabolic features and supporting clinical decision-making, and discusses key technical challenges and future directions. It aims to serve as a valuable reference for further research and clinical translation in this field. ]]></description>
<pubDate>Tue,20 Jan 2026 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
